DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding

Completed · Phase 4

Conditions studied: Dysfunctional Uterine Bleeding

In brief

The purpose of this study is to investigate the effectiveness and acceptability of high dose MPA (20mg oral 3 times a day) for 3 days combined with an injection of DMPA 150 mg intramuscularly in the treatment of acute heavy, prolonged uterine bleeding who have been identified as being eligible for outpatient management

Key facts

Study ID

NCT01148420

Run by

Women's Health Care Clinic, Torrance, California

People needed

48

Starts

2009-01-01

Expected to finish

2012-07-01

Last updated by the study team

2014-03-13

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Age 18- 50
• Non-pregnant
• Candidate for outpatient management
• Able to understand and follow instructions
• Vital signs stable
• No severe anemia
• No medical conditions requiring transfusion

You may not qualify if…

• Pregnancy
• Breast cancer current or in last 5 years
• Allergy to MPA or DMPA
• Previous hormonal therapies
• Unstable vital signs
• Bleeding excessive enough to require surgical therapy or hospital admission
• Desire for pregnancy in next 6 months

Where it is running

• Harbor-UCLA Urgent Care — Torrance, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.